The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

EuroIntervention 2018;14:224-231 published online March 2018. DOI: 10.4244/EIJ-D-18-00024

1. Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; 2. I Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; 3. DZHK (German Centre for Cardiovascular Research), par

Aims: The ultrathin-strut biodegradable polymer sirolimus-eluting stent (SES) is a new-generation drug-eluting stent (DES) developed to improve the percutaneous treatment of patients with

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Single guiding catheter retrograde CTO recanalisation facilitated by trapping technique: introducing the modified rendezvous technique